Doi.org/10.1093/inthealth/ihx038
Revision as of 12:58, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == For as long as necessary: examining 30 years of Merck & Co., Inc.’s focus on achieving elimination of onchocerciasis and lymphatic filariasis ; Kenneth M Gustavsen Brenda D Colatrella Theresa McCoy; NULL; 11/23/2017; https://doi.org/10.1093/inthealth/ihx038 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target ArticleEdit
For as long as necessary: examining 30 years of Merck & Co., Inc.’s focus on achieving elimination of onchocerciasis and lymphatic filariasis ; Kenneth M Gustavsen Brenda D Colatrella Theresa McCoy; NULL; 11/23/2017; https://doi.org/10.1093/inthealth/ihx038
ReasonsEdit
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.